Acute Lymphoblastic Leukemia Panel - Disclosures
|
Panel Member
|
Ramzi Abboud MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Peter Abdelmessieh DO, MSc |
|
Product/Speakers Bureau
|
| Amgen Inc. |
|
Date Completed
|
11/03/2024 |
|
Panel Member
|
Ibrahim Aldoss MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ajibola Awotiwon MBBS, MSc |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Talha Badar MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Shakthi Bhaskar MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Patrick Burke MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Weina Chen MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel DeAngelo MD, PhD |
|
Grant/Research Support
|
| AbbVie, Inc. | Blueprint Medicines | Cogent | GlycoMimetics, Inc. |
|
Date Completed
|
03/24/2025 |
|
Panel Member
|
Shira Dinner MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Amir Fathi MD |
|
Grant/Research Support
|
| AbbVie, Inc. | Bristol Myers Squibb | Servier |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Meghan Fay BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jordan Gauthier MD, MSc |
|
Grant/Research Support
|
| Angiocrine Bioscience | CARGO Therapeutics | Celgene Corporation | Faron Pharmaceuticals | Juno Therapeutics, Inc. |
|
Date Completed
|
08/16/2024 |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael Haddadin MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anne Holbrook PharmD, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jordan Holmes MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nitin Jain MD |
|
Grant/Research Support
|
| AbbVie, Inc. | Adaptive Biotechnologies | ADC Therapeutics | AstraZeneca Pharmaceuticals LP | Autolus | BeiGene | Bristol Myers Squibb | Carna Biosciences | Cellectis | Eli Lilly and Company | Fate Therapeutics | Genentech, Inc. | Gilead Sciences, Inc. | MingSight | Newave | Novartis Pharmaceuticals Corporation | Nurix | Pharmacyclics | Precision Biosciences | Sana Biotechnology | Takeda Pharmaceuticals North America, Inc. | TriArm Therapeutics |
|
Date Completed
|
05/13/2025 |
|
Panel Member
|
Brian Jonas MD, PhD |
|
Grant/Research Support
|
| AbbVie, Inc. | Amgen Inc. | Aptose | AROG | Biomea | Bristol Myers Squibb | Celgene Corporation | Forma | Forty Seven, Inc. | Genentech, Inc. | Gilead Sciences, Inc. | GlycoMimetics, Inc. | Hanmi | Immune-Onc | Jazz Pharmaceuticals Inc. | Kymera | Loxo | Pfizer Inc. | Pharmacyclics | Treadwell |
|
Date Completed
|
07/21/2024 |
|
Panel Member
|
Michaela Liedtke MD |
|
Grant/Research Support
|
| AbbVie, Inc. | Allogene | Biomea | Bristol Myers Squibb | Caelum | Gilead Sciences, Inc. | Janssen Pharmaceutica Products, LP | SeaGen |
|
Date Completed
|
06/13/2024 |
|
Panel Member
|
Chenyu Lin MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aaron Logan MD, PhD, MPhil |
|
Grant/Research Support
|
| Amgen Inc. | Autolus | Kite Pharma | sanofi-aventis U.S. |
|
Date Completed
|
05/12/2025 |
|
Panel Member
|
Meixiao Long MD, PhD |
|
Grant/Research Support
|
| AURIVA HEALTH INC. applied STTR /SBIR grants ( not funded) |
|
Date Completed
|
08/13/2024 |
|
Panel Member
|
Selina Luger MD |
|
Grant/Research Support
|
| Celgene Corporation | Kura Oncology, Inc. | Takeda Pharmaceuticals North America, Inc. |
|
Date Completed
|
08/13/2024 |
|
Panel Member
|
James Mangan MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ryan Mattison MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lourdes Mendez MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Priyanka Nanjireddy MBBS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristen Osiniak MEd |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jae Park MD |
|
Equity Interest/Stock Options
|
| Curocel |
|
Date Completed
|
03/13/2025 |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sravanti Rangaraju MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Caner Saygin MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marc Schwartz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bijal Shah MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Paul Shami MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Katie Stehman MMS, PA-C |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Samantha Tamburro BSN, RN, CPON |
|
Salary
|
| Flatiron Health, Inc. |
|
Date Completed
|
10/24/2024 |
|
Panel Member
|
Benjamin Tomlinson MD |
|
Grant/Research Support
|
| Bristol Myers Squibb |
|
Date Completed
|
09/11/2024 |
|
Panel Member
|
Eunice Wang MD |
|
Product/Speakers Bureau
|
| Astellas Pharma US, Inc. | Dava Oncology | Pfizer Inc. |
|
Royalty Income
|
| UpToDate |
|
Date Completed
|
08/25/2024 |
|
Panel Member
|
Jonathan Webster MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
